A Case of Persistent Metastatic Gestational Trophoblastic Disease after Partial Hydatidiform Mole / 대한산부인과학회지
Korean Journal of Obstetrics and Gynecology
; : 240-246, 2005.
Article
en Ko
| WPRIM
| ID: wpr-123797
Biblioteca responsable:
WPRO
ABSTRACT
Persistent tumor, usually non-metastatic, develops in approximately 4% of patients with a partial mole, and chemotherapy is required to achieve remission. Following evacuation of hydatidiform mole, careful hCG monitoring is mandatory since it is the most reliable and sensitive method for the early detection of gestational trophoblastic disease. In carefully selected patients in whom the risk of developing gestational trophoblastic disease is significant or when the availability of hCG testing is suboptimal, chemoprophylaxis has been shown to decrease the risk of gestational trophoblastic tumor. We report here a case of patient, 23- year-old woman who experienced unusual course after the evacuation of a partial mole and markedly elevated serum beta-hCG levels. The patient developed persistent metastatic gestational trophoblastic disease and was successfully treated with 3 courses of EMA-CO.
Palabras clave
Texto completo:
1
Banco de datos:
WPRIM
Asunto principal:
Mola Hidatiforme
/
Neoplasias Trofoblásticas
/
Quimioprevención
/
Enfermedad Trofoblástica Gestacional
/
Quimioterapia
Tipo de estudio:
Screening_studies
Límite:
Female
/
Humans
/
Pregnancy
Idioma:
Ko
Revista:
Korean Journal of Obstetrics and Gynecology
Año:
2005
Tipo del documento:
Article